Adequacy of therapy for people with both COPD and heart failure in the UK : historical cohort study
| dc.contributor.author | Kostikas, Konstantinos | |
| dc.contributor.author | Rhee, Chin Kook | |
| dc.contributor.author | Hurst, John R. | |
| dc.contributor.author | Agostoni, Piergiuseppe | |
| dc.contributor.author | Cao, Hui | |
| dc.contributor.author | Fogel, Robert | |
| dc.contributor.author | Jones, Rupert | |
| dc.contributor.author | Kocks, Janwillem WH | |
| dc.contributor.author | Mezzi, Karen | |
| dc.contributor.author | Ming, Simon Wan Yau | |
| dc.contributor.author | Ryan, Ronan | |
| dc.contributor.author | Price, David B. | |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.date.accessioned | 2020-06-02T09:30:01Z | |
| dc.date.available | 2020-06-02T09:30:01Z | |
| dc.date.issued | 2020-06-02 | |
| dc.description | Acknowledgments We thank Derek Skinner for his contributions to the data acquisition and handling and Carole Nicholls and Priyanka Raju Konduru for statistical support. Writing and editorial support was provided by Elizabeth V. Hillyer, DVM, supported by Novartis Pharma AG, Basel, Switzerland. Funding This work was supported by Novartis. Employees of the sponsor (listed as authors) participated in the study design, interpretation of the results, writing of the report, and the decision to submit the paper for publication. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 12 | |
| dc.format.extent | 2870136 | |
| dc.identifier | 170263824 | |
| dc.identifier | 8466716e-80b6-4ceb-9be0-020ce50c382e | |
| dc.identifier | 32581622 | |
| dc.identifier.citation | Kostikas, K, Rhee, C K, Hurst, J R, Agostoni, P, Cao, H, Fogel, R, Jones, R, Kocks, J WH, Mezzi, K, Ming, S W Y, Ryan, R & Price, D B 2020, 'Adequacy of therapy for people with both COPD and heart failure in the UK : historical cohort study', Pragmatic and Observational Research, vol. 11, pp. 55-66. https://doi.org/10.2147/POR.S250451 | en |
| dc.identifier.doi | 10.2147/POR.S250451 | |
| dc.identifier.issn | 1179-7266 | |
| dc.identifier.uri | https://hdl.handle.net/2164/14422 | |
| dc.identifier.vol | 11 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Pragmatic and Observational Research | en |
| dc.subject | beta-blocker | en |
| dc.subject | long-acting bronchodilator | en |
| dc.subject | integrated care | en |
| dc.subject | multimorbidity | en |
| dc.subject | R Medicine (General) | en |
| dc.subject.lcc | R1 | en |
| dc.title | Adequacy of therapy for people with both COPD and heart failure in the UK : historical cohort study | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Kostikas_et_al_POR_AdequacyOfTherapy_VoR.pdf
- Size:
- 2.74 MB
- Format:
- Adobe Portable Document Format
